Biopharma ScieGen is expanding its manufacturing operations on Long Island and adding over 100 jobs. The $15 million expansion will help ScieGen, a subsidiary of Bactolac Pharmaceutical, bolster its production of prescription drugs to meet growing demands. The company plans to convert 65,000 s/f of former warehouse space at its facility at 33 Oser Avenue in Hauppauge into manufacturing space with washrooms, an office, labs and a cafeteria. The company says it will use Long Island-based vendors to make the space FDA compliant. Learn More